Literature DB >> 22854640

Paraoxonase 1 (PON1) C/T-108 association with longitudinal mean arterial blood pressure.

Vibha Bhatnagar1, Lin Liu, Caroline M Nievergelt, Erin Richard, Victoria H Brophy, Braj Pandey, Michael S Lipkowitz, Daniel T O'Connor.   

Abstract

BACKGROUND: Blood pressure is a complex quantitative trait with a strong genetic component. In this study, we leveraged the Veterans Affairs electronic medical record system to explore the relationship between Paraoxonase 1 (PON1)-108 C/T (rs705379) and mean arterial blood pressure (MAP).
METHODS: Outpatient blood pressure data over an approximate 8-year period was collected from the Veterans Affairs Hypertensive Cohort (N = 1,302). Association between genotype and longitudinal MAP was further explored using a random effects model controlling for age, ancestry, renal function, and other determinants of blood pressure. To control for population stratification, principal component groupings based on ancestry informative markers in this dataset were included as covariates (in addition to self-identified ancestry). Data from the African American Study of Kidney Disease and Hypertension (AASK, N = 857) was used to confirm significant findings in an independent cohort.
RESULTS: There was a significant interaction between PON1-108 C/T genotype and follow-up age group. At a younger age (<50 years), there was an estimated 2.53 mm Hg (95% confidence interval: 1.06, 4.00) increase in MAP with each additional C-allele. At the older age groups, there were no significant associations between PON1-108 C/T genotype and MAP. Using data from the AASK trial, the C-allele at PON1-108 C/T was significantly associated with a higher MAP (P = 0.005) but only among younger participants (<54 years).
CONCLUSIONS: The PON1-108 polymorphism may be associated with MAP in an age-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854640      PMCID: PMC3515680          DOI: 10.1038/ajh.2012.106

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  25 in total

1.  Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

Authors:  G P Jarvik; L S Rozek; V H Brophy; T S Hatsukami; R J Richter; G D Schellenberg; C E Furlong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

Review 2.  Genetics of essential hypertension: from families to genes.

Authors:  Cristina Barlassina; Chiara Lanzani; Paolo Manunta; Giuseppe Bianchi
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

3.  Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.

Authors:  Gail P Jarvik; Thomas S Hatsukami; Chris Carlson; Rebecca J Richter; Rachel Jampsa; Victoria H Brophy; Sadie Margolin; Mark Rieder; Deborah Nickerson; Gerard D Schellenberg; Patrick J Heagerty; Clement E Furlong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-12       Impact factor: 8.311

4.  Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.

Authors:  R Malin; O Järvinen; T Sisto; T Koivula; T Lehtimäki
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

5.  Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.

Authors:  H Jakubowski
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  The VA Hypertension Primary Care Longitudinal Cohort: Electronic medical records in the post-genomic era.

Authors:  Rany M Salem; Braj Pandey; Erin Richard; Maple M Fung; Erin P Garcia; Victoria H Brophy; Nicholas J Schork; Daniel T O'Connor; Vibha Bhatnagar
Journal:  Health Informatics J       Date:  2010-12       Impact factor: 2.681

7.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

8.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

9.  Vitamin C and E intake is associated with increased paraoxonase activity.

Authors:  Gail P Jarvik; Nancey Trevanian Tsai; Laura A McKinstry; Roohi Wani; Victoria H Brophy; Rebecca J Richter; Gerard D Schellenberg; Patrick J Heagerty; Thomas S Hatsukami; Clement E Furlong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

10.  Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans.

Authors:  Manjunath N Rao; Philippe Marmillot; Maoka Gong; David A Palmer; Leonard B Seeff; Doris B Strader; M Raj Lakshman
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

View more
  1 in total

1.  Gene-age interactions in blood pressure regulation: a large-scale investigation with the CHARGE, Global BPgen, and ICBP Consortia.

Authors:  Jeannette Simino; Gang Shi; Joshua C Bis; Daniel I Chasman; Georg B Ehret; Xiangjun Gu; Xiuqing Guo; Shih-Jen Hwang; Eric Sijbrands; Albert V Smith; Germaine C Verwoert; Jennifer L Bragg-Gresham; Gemma Cadby; Peng Chen; Ching-Yu Cheng; Tanguy Corre; Rudolf A de Boer; Anuj Goel; Toby Johnson; Chiea-Chuen Khor; Carla Lluís-Ganella; Jian'an Luan; Leo-Pekka Lyytikäinen; Ilja M Nolte; Xueling Sim; Siim Sõber; Peter J van der Most; Niek Verweij; Jing Hua Zhao; Najaf Amin; Eric Boerwinkle; Claude Bouchard; Abbas Dehghan; Gudny Eiriksdottir; Roberto Elosua; Oscar H Franco; Christian Gieger; Tamara B Harris; Serge Hercberg; Albert Hofman; Alan L James; Andrew D Johnson; Mika Kähönen; Kay-Tee Khaw; Zoltan Kutalik; Martin G Larson; Lenore J Launer; Guo Li; Jianjun Liu; Kiang Liu; Alanna C Morrison; Gerjan Navis; Rick Twee-Hee Ong; George J Papanicolau; Brenda W Penninx; Bruce M Psaty; Leslie J Raffel; Olli T Raitakari; Kenneth Rice; Fernando Rivadeneira; Lynda M Rose; Serena Sanna; Robert A Scott; David S Siscovick; Ronald P Stolk; Andre G Uitterlinden; Dhananjay Vaidya; Melanie M van der Klauw; Ramachandran S Vasan; Eranga Nishanthie Vithana; Uwe Völker; Henry Völzke; Hugh Watkins; Terri L Young; Tin Aung; Murielle Bochud; Martin Farrall; Catharina A Hartman; Maris Laan; Edward G Lakatta; Terho Lehtimäki; Ruth J F Loos; Gavin Lucas; Pierre Meneton; Lyle J Palmer; Rainer Rettig; Harold Snieder; E Shyong Tai; Yik-Ying Teo; Pim van der Harst; Nicholas J Wareham; Cisca Wijmenga; Tien Yin Wong; Myriam Fornage; Vilmundur Gudnason; Daniel Levy; Walter Palmas; Paul M Ridker; Jerome I Rotter; Cornelia M van Duijn; Jacqueline C M Witteman; Aravinda Chakravarti; Dabeeru C Rao
Journal:  Am J Hum Genet       Date:  2014-06-19       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.